Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
32371 | 109 | 32.6 | 68% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
132 | 22818 | ANGIOTENSIN II//ANGIOTENSIN 1 7//RENIN ANGIOTENSIN SYSTEM |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AMBIENTES EXTREMOS | Address | 1 | 50% | 1% | 1 |
2 | EPICAPTOPRIL | Author keyword | 1 | 50% | 1% | 1 |
3 | PAN NEPHROPATHY | Author keyword | 1 | 50% | 1% | 1 |
4 | PHARM BIOCHEM PHYS CHEM | Address | 1 | 50% | 1% | 1 |
5 | PHYS CHEM PROGRAMA RADICALES LIB | Address | 1 | 50% | 1% | 1 |
6 | INVEST MED ALBERT E EIN | Address | 1 | 29% | 2% | 2 |
7 | CYSTEAMINE INDUCED DUODENAL ULCER | Author keyword | 0 | 33% | 1% | 1 |
8 | KARAJ PROD | Address | 0 | 33% | 1% | 1 |
9 | PUSHCHINO HOSP | Address | 0 | 33% | 1% | 1 |
10 | ANGIOTENSION II RECEPTOR BLOCKER | Author keyword | 0 | 25% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANGIOTENSIN CONVERTASE INHIBITORS | 1 | 50% | 1% | 1 |
2 | CARDIAC CONTRACTILE RESPONSE | 1 | 50% | 1% | 1 |
3 | PROOXIDANT PROPERTIES | 1 | 19% | 3% | 3 |
4 | SCAVENGE | 0 | 33% | 1% | 1 |
5 | SUPEROXIDE RADICAL FORMATION | 0 | 33% | 1% | 1 |
6 | GRANULAR CELL CULTURE | 0 | 20% | 1% | 1 |
7 | INHIBITOR CAPTOPRIL | 0 | 20% | 1% | 1 |
8 | 5 6 NEPHRECTOMY | 0 | 14% | 1% | 1 |
9 | CYSTEAMINE DIOXYGENASE | 0 | 13% | 1% | 1 |
10 | FLUORESCENCE DEVELOPMENT | 0 | 13% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
INFLUENCE OF ACE INHIBITORS ON FREE-RADICALS AND REPERFUSION INJURY - PHARMACOLOGICAL CURIOSITY OR THERAPEUTIC HOPE | 1991 | 28 | 29 | 21% |
Recent advances in the assessment of the antioxidant capacity of pharmaceutical drugs: from in vitro to in vivo evidence | 2010 | 4 | 47 | 4% |
ANTIOXIDANT DRUG MECHANISMS - TRANSITION METAL-BINDING AND VASODILATION | 1992 | 28 | 25 | 8% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AMBIENTES EXTREMOS | 1 | 50% | 0.9% | 1 |
2 | PHARM BIOCHEM PHYS CHEM | 1 | 50% | 0.9% | 1 |
3 | PHYS CHEM PROGRAMA RADICALES LIB | 1 | 50% | 0.9% | 1 |
4 | INVEST MED ALBERT E EIN | 1 | 29% | 1.8% | 2 |
5 | KARAJ PROD | 0 | 33% | 0.9% | 1 |
6 | PUSHCHINO HOSP | 0 | 33% | 0.9% | 1 |
7 | FISIOL FISIOPATOL DESARROLLO | 0 | 25% | 0.9% | 1 |
8 | SHAHRIVAR HOSP 17 | 0 | 25% | 0.9% | 1 |
9 | MEDICBM | 0 | 20% | 0.9% | 1 |
10 | CARDIOL INVEST | 0 | 14% | 0.9% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000221369 | MAGNETOCHEMICAL PROPERTIES//EDXD//STRUCTURAL DIFFUSION MODEL |
2 | 0.0000161689 | PATOL VASC NEFROL EXPT//VASC RENAL PATHOL//MED ALFREDO LANARI |
3 | 0.0000159270 | ADRIAMYCIN NEPHROPATHY//PUROMYCIN AMINONUCLEOSIDE//DOXORUBICIN NEPHROPATHY |
4 | 0.0000125353 | ZOFENOPRIL//INFARCT EXPANSION//ANGIOTENSIN II AT1 RECEPTOR BLOCKADE |
5 | 0.0000103213 | AMBROXOL//BROMHEXINE//AMBROXOL HYDROCHLORIDE |
6 | 0.0000088800 | ALPHA TOCOPHEROL ANALOG//MYOCARDIAL STUNNING//CORONARY ARTERY REPERFUSION |
7 | 0.0000061662 | PROTEIN OXIDATION//METAL CATALYZED OXIDATION//PROTEIN PEROXIDES |
8 | 0.0000061229 | OCULAR RENIN ANGIOTENSIN SYSTEM//REN 2 RAT//S PHARMACOL MOL BIOL |
9 | 0.0000060685 | NANOBIOTECHNOL GRP//PERTHIYL RADICALS//BIOTECHNOL CHEM ENVIRONM SCI |
10 | 0.0000059727 | BIOQUIM ENVELHECIMENTO DOENCAS CORRELACIONA//NPPG//BIOQUIM METABOL |